MOR - MorphoSys drops amid speculation Novartis could walk from deal
2024-02-06 12:21:34 ET
More on MorphoSys
- Novartis And MorphoSys Are A Perfect Match
- MorphoSys: Positive Pelabresib Data Finally Unlocking Upside
- MorphoSys: A Buying Opportunity Following Mixed Phase 3 Results In Myelofibrosis
- Incyte buys global rights for tafasitamab from MorphoSys
- MorphoSys jumps amid report Novartis in takeover talks; Karyopharm surges in sympathy (update)